Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/21770
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKonstandi, M.en
dc.contributor.authorKostakis, D.en
dc.contributor.authorJohnson, E.en
dc.contributor.authorLang, M. A.en
dc.contributor.authorMarselos, M.en
dc.date.accessioned2015-11-24T19:17:22Z-
dc.date.available2015-11-24T19:17:22Z-
dc.identifier.issn0378-7966-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/21770-
dc.rightsDefault Licence-
dc.subjectAdrenergic alpha-2 Receptor Agonistsen
dc.subjectAdrenergic alpha-Agonists/pharmacologyen
dc.subjectAnimalsen
dc.subjectBenzo(a)pyrene/*pharmacologyen
dc.subjectCarcinogens/*pharmacologyen
dc.subjectCytochrome P-450 CYP1A1/metabolismen
dc.subjectCytochrome P-450 CYP2B1/metabolismen
dc.subjectCytochrome P-450 Enzyme System/*metabolismen
dc.subjectEnzyme Induction/drug effectsen
dc.subjectImidazoles/pharmacologyen
dc.subjectMaleen
dc.subjectMedetomidineen
dc.subjectOxidoreductases/metabolismen
dc.subjectRatsen
dc.subjectRats, Wistaren
dc.subjectReceptors, Adrenergic, alpha-2/*metabolismen
dc.subjectStress, Psychologicalen
dc.titleEvidence of alpha2-adrenoceptor involvement in B[alpha]P induction processes of drug-metabolizing enzymes: the effect of stressen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/10323332-
heal.identifier.secondaryhttp://www.springerlink.com/content/x745208h20664p01/-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate1998-
heal.abstractCentral to the appropriate regulation of behavioral and physiological changes induced by stress are the noradrenergic neuronal systems which have been implicated in a large number of stress-induced pathophysiological states. Endoplasmic reticulum-bound cytochromes (CYPs) play a crucial role in drug metabolism, resulting in deactivation or formation of reactive derivatives. In turn, these products may be responsible for the chemotherapeutic, mutagenic or carcinogenic properties of the parent compound. The present study assesses the effect of a specific alpha2- adrenoceptor agonist, dexmedetomidine (DEXT), on stress-induced modification of cytochrome activity in rats using a restraint stress model. The results indicated that activation of the alpha2-adrenoceptor with DEXT did not alter basal hepatic methoxyresorufin 7-dealkylase (MROD). On the other hand, it appeared to enhance MROD in benzo[alpha]pyrene (B[alpha]P) treated animals. Of interest was the finding that stress blocked DEXT-induced MROD enhancement in B[alpha]P- treated rats. In addition, DEXT had no effect on basal hepatic pentoxyresorufin 7-dealkylase (PROD), while it further enhanced the strong induction by B[alpha]P. Stress was also found to block this effect. Hepatic ethoxyresorufin 7-dealkylase (EROD) activity was strongly increased by B[alpha]P; this effect was enhanced by DEXT. In contrast, the DEXT enhanced induction was further strengthened by stress. These findings suggest that alpha2-adrenoceptors may modulate the induction of cytochromes CYP1A1, 1A2 and 2B1 by B[alpha]P in rats and that stress may modify this process. In particular, stress may regulate the inducibility of P4501A1 activity by B[alpha]P via mechanisms related to alpha2-adrenoceptors.en
heal.journalNameEur J Drug Metab Pharmacokineten
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons